[First i.m., now oral. COX-2 inhibitor in acute lumbago].
D000208:Acute Disease; D000284:Administration, Oral; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D007273:Injections, Intramuscular; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D017116:Low Back Pain / Q000188:drug therapy*; D000077239:Meloxicam; D008565:Membrane Proteins; D010894:Piroxicam / Q000008:administration & dosage*; D011451:Prostaglandin-Endoperoxide Synthases; D016032:Randomized Controlled Trials as Topic; D013843:Thiazines / Q000008:administration & dosage*; D013844:Thiazoles / Q000008:administration & dosage*
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D013843:Thiazines; D013844:Thiazoles; D010894:Piroxicam; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D000077239:Meloxicam